Chanda D., Otoupalova E., Smith S.R., Volckaert T., De Langhe S. P., Thannickal V.J. 2019. Developmental pathways in the pathogenesis of lung fibrosis. Mol. Aspects Med. 65, 56–69.
Article CAS PubMed Google Scholar
Hu H.H., Chen D.Q., Wang Y.N., Feng Y.L., Cao G., Vaziri N.D., Zhao Y.Y. 2018. New insights into TGF-β/Smad signaling in tissue fibrosis. Chem. Biol. Interact. 292, 76–83.
Article CAS PubMed Google Scholar
Hata A., Lagna G., Massagué J., Hemmati-Brivanlou A. 1998. Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. Genes Dev. 12, 186–197.
Article CAS PubMed PubMed Central Google Scholar
Hayashi H., Abdollah S., Qiu Y., Cai J., Xu Y.Y., Grinnell B.W., Richardson M.A., Topper J.N., Gimbrone M.A., Jr, Wrana J.L., Falb D. 1997. The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling. Cell. 89, 1165–1173.
Article CAS PubMed Google Scholar
Imamura T., Takase M., Nishihara A., Oeda E., Hanai J., Kawabata M., Miyazono K. 1997. Smad6 inhibits signalling by the TGF-beta superfamily. Nature. 389, 622–626.
Article CAS PubMed Google Scholar
Nakao A., Afrakhte M., Morén A., Nakayama T., Christian J.L., Heuchel R., Itoh S., Kawabata, M., Heldin N.E., Heldin C.H., ten Dijke P. 1997. Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature. 389, 631–635.
Article CAS PubMed Google Scholar
Su D.N., Wu S.P., Xu S.Z. 2020. Mesenchymal stem cell-based Smad7 gene therapy for experimental liver cirrhosis. Stem Cell Res. Ther. 11, 395.
Article CAS PubMed PubMed Central Google Scholar
Li X.F., Zhang S.H., Liu G.F., Yu S.N. 2022. miR-363 alleviates detrusor fibrosis via the TGF-β1/Smad signaling pathway by targeting Col1a2 in rat models of STZ-induced T2DM. Mol. Ther. Nucleic Acids. 29, 1142–1153.
Nagarajan R.P., Zhang J., Li W., Chen Y. 1999. Regulation of Smad7 promoter by direct association with Smad3 and Smad4. J. Biol. Chem. 274, 33412–33418.
Article CAS PubMed Google Scholar
Yan X., Liao H., Cheng M., Shi X., Lin X., Feng X.H., Chen Y.G. 2016. Smad7 protein interacts with receptor-regulated Smads (R-Smads) to inhibit transforming growth factor-β (TGF-β)/Smad signaling. J. Biol. Chem. 291, 382–392.
Article CAS PubMed Google Scholar
Meng L., Zhang X., Wang H., Dong H., Gu X., Yu X., Liu Y. 2019. Yangyin Yiqi Mixture ameliorates bleomycin-induced pulmonary fibrosis in rats through inhibiting TGF-β1/Smad pathway and epithelial to mesenchymal transition. Evidence-Based Complementary Altern. Med. 2019, 2710509.
Gao C., Chang H., Wang Z., Jia M., Li Q., Li X., Shi S., Bu H. 2023. The mechanism of Qingwen Gupi decoction on pulmonary fibrosis based on metabolomics and intestinal flora. J. Appl. Microbial. 134, lxac035.
Huang S., Li Y., Wu P., Xiao Y., Duan N., Quan J., Du W. 2020. microRNA-148a-3p in extracellular vesicles derived from bone marrow mesenchymal stem cells suppresses SMURF1 to prevent osteonecrosis of femoral head. J. Cell. Mol. Med. 24, 11512–11523.
Article CAS PubMed PubMed Central Google Scholar
Gifford C.C., Tang J., Costello A., Khakoo N.S., Nguyen T.Q., Goldschmeding R., Higgins P. J., Samarakoon R. 2021. Negative regulators of TGF-β1 signaling in renal fibrosis; pathological mechanisms and novel therapeutic opportunities. Clin. Sci. (London). 135, 275–303.
Kim M.S., Baek A.R., Lee J.H., Jang A.S., Kim D.J., Chin S.S., Park S.W. 2019. IL-37 attenuates lung fibrosis by inducing autophagy and regulating TGF-β1 production in mice. J. Immunol. (Baltimore). 203, 2265–2275.
Article CAS PubMed Google Scholar
Liu M.W., Su M.X., Tang D.Y., Hao L., Xun X.H., Huang Y.Q. 2019. Ligustrazin increases lung cell autophagy and ameliorates paraquat-induced pulmonary fibrosis by inhibiting PI3K/Akt/mTOR and hedgehog signalling via increasing miR-193a expression. BMC Pulm. Med. 19, 35.
Article PubMed PubMed Central Google Scholar
Baek A.R., Hong J., Song K.S., Jang A.S., Kim D.J., Chin S.S., Park S.W. 2020. Spermidine attenuates bleomycin-induced lung fibrosis by inducing autophagy and inhibiting endoplasmic reticulum stress (ERS)-induced cell death in mice. Exp. Mol. Med. 52, 2034–2045.
Article CAS PubMed PubMed Central Google Scholar
Chitra P., Saiprasad G., Manikandan R., Sudhandiran G. 2015. Berberine inhibits Smad and non-Smad signaling cascades and enhances autophagy against pulmonary fibrosis. J. Mol. Med. (Berl.). 93, 1015–1031.
Article CAS PubMed Google Scholar
d’Alessandro M., Conticini E., Bergantini L., Cameli P., Cantarini L., Frediani B., Bargagli E. 2022. Neutrophil extracellular traps in ANCA-associated vasculitis and interstitial lung disease: A scoping review. Life (Basel). 12 (2), 317.
Article PubMed PubMed Central Google Scholar
Saleh M., Fotook Kiaei S.Z., Kavianpour M. 2022. Application of Wharton jelly-derived mesenchymal stem cells in patients with pulmonary fibrosis. Stem Cell Res. Ther. 13, 71.
Article CAS PubMed PubMed Central Google Scholar
Sapkota G., Alarcón C., Spagnoli F.M., Brivanlou A.H., Massagué J. 2007. Balancing BMP signaling through integrated inputs into the Smad1 linker. Mol. Cell. 25, 441–454.
Article CAS PubMed Google Scholar
Song M.K., Lee J.H., Ryoo I.G., Lee S.H., Ku S.K., Kwak M.K. 2019. Bardoxolone ameliorates TGF-β1-associated renal fibrosis through Nrf2/Smad7 elevation. Free Radical Biol. Med. 138, 33–42.
Li S.X., Li C., Pang X.R., Zhang J., Yu G.C., Yeo A.J., Lavin M.F., Shao H., Jia Q., Peng C. 2021. Metformin attenuates silica-induced pulmonary fibrosis by activating autophagy via the AMPK-mTOR signaling pathway. Front. Pharmacol. 12, 719589.
Article CAS PubMed PubMed Central Google Scholar
Lu Y., Zhong W., Liu Y., Chen W., Zhang J., Zeng Z., Huang H., Qiao Y., Wan X., Meng X., Cai S., Dong H. 2022. Anti-PD-L1 antibody alleviates pulmonary fibrosis by inducing autophagy via inhibition of the PI3K/Akt/mTOR pathway. Int. Immunopharmacol. 104, 108504.
Article CAS PubMed Google Scholar
Lv X., Li K., Hu Z. 2020. Autophagy and pulmonary fibrosis. Adv. Exp. Med. Biol. 1207, 569–579.
Article CAS PubMed Google Scholar
Mizushima N., Komatsu M. 2011. Autophagy: Renovation of cells and tissues. Cell. 147, 728–741.
Article CAS PubMed Google Scholar
Murphy G., Cockett M.I., Ward R.V., Docherty A.J. 1991. Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP). Biochem. J. 277 (Pt 1), 277–279.
Article CAS PubMed PubMed Central Google Scholar
Sires U.I., Murphy G., Baragi V.M., Fliszar C.J., Welgus H.G., Senior R.M. 1994. Matrilysin is much more efficient than other matrix metalloproteinases in the proteolytic inactivation of alpha 1-antitrypsin. Biochem. Biophys. Res. Commun. 204, 613–620.
Article CAS PubMed Google Scholar
Zheng C.M., Lu K.C., Chen Y.J., Li C.Y., Lee Y.H., Chiu H.W. 2022. Matrix metalloproteinase-7 promotes chronic kidney disease progression via the induction of inflammasomes and the suppression of autophagy. Biomed. Pharmacother. 154, 113565.
留言 (0)